Safety and Efficacy of Polyetheretherketone (PEEK) Cages and Cadaveric Allografts in Transforaminal Lumbar Interbody Fusion (TLIF) for Treating Lumbar Pyogenic Spondylodiscitis

<div>A 68-year-old male with lumbar pyogenic spondylodiscitis. (a) Preoperative lumbar spine X-ray. (b) Preoperative lumbar CT image. (c) T1-weighted image showed hypointensity of L4–L5 vertebral body. (d) T2-weighted fat-suppression sequence showed relative homogeneous enhancement of vertebral bodies and remarkable hyperintensity of the disc. (e, f) Postoperative lumbar radiological images. (g, h) Radiological images at 3 months postoperatively. (i, j) The CT scan showed solid interbody fusion at 1 year after surgery.</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: Safety and Efficacy of Polyetheretherketone (PEEK) Cages and Cadaveric Allografts in Transforaminal Lumbar Interbody Fusion (TLIF) for Treating Lumbar Pyogenic Spondylodiscitis 

Figure 1 | Safety and Efficacy of Polyetheretherketone (PEEK) Cages and Cadaveric Allografts in Transforaminal Lumbar Interbody Fusion (TLIF) for Treating Lumbar Pyogenic Spondylodiscitis 